USPTO Trademark 98431531
USPTO Trademark 98431531 is a USPTO trademark filed by BTG International Inc.. Status: Pending.
Trademark Facts
| Mark | USPTO Trademark 98431531 |
|---|---|
| Serial Number | 98431531 |
| Status | Pending |
| Filing Date | 2024-03-04 |
| Mark Type | Design |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | BTG International Inc. |
| Attorney of Record | Karl M. Zielaznicki, Esq. |
| Prosecution Events | 21 |
| Latest Event | EXRA on 2026-02-24 |
Goods & Services
pharmaceutical preparation, namely, a recombinant, human monoclonal antibody antigen-binding fragment designed to reverse the antiplatelet activity of ticagrelor in major bleeding and urgent surgery situations.